RNAi-Mediated Knock-Down of Arylamine N-acetyltransferase-1 Expression Induces E-cadherin Up-Regulation and Cell-Cell Contact Growth Inhibition
2011

NAT1 Knock-Down Affects Cell Growth and E-cadherin Expression

Sample size: 3 publication 10 minutes Evidence: moderate

Author Information

Author(s): Tiang Jacky M., Butcher Neville J., Cullinane Carleen, Humbert Patrick O., Minchin Rodney F.

Primary Institution: School of Biomedical Sciences, University of Queensland

Hypothesis

Does the knock-down of Arylamine N-acetyltransferase-1 (NAT1) affect cell growth and E-cadherin expression in cancer cells?

Conclusion

The study found that NAT1 knock-down inhibits cell growth and increases E-cadherin expression, suggesting NAT1 may be a potential drug target in cancer therapy.

Supporting Evidence

  • NAT1 knock-down led to a significant decrease in cell viability at confluence.
  • E-cadherin protein expression increased in NAT1 knock-down cells compared to control cells.
  • NAT1 knock-down cells showed altered cell morphology and reduced anchorage-independent growth.

Takeaway

When scientists turned off a gene called NAT1 in cancer cells, the cells grew slower and made more of a protein called E-cadherin, which helps cells stick together.

Methodology

The study used shRNA to knock down NAT1 in HT-29 colon adenocarcinoma cells and assessed changes in cell growth, morphology, and E-cadherin expression.

Potential Biases

Potential off-target effects of shRNA were considered but deemed unlikely.

Limitations

The NAT1 knock-down effect was not maintained in vivo, and the study did not investigate the metastatic potential of the cells.

Statistical Information

P-Value

p<0.05

Confidence Interval

95% CI 10.6–11.0

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0017031

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication